Newcastle University

Eight healthy babies were born in Britain using an experimental technique that combines DNA from three people to prevent mothers from passing devastating mitochondrial diseases to their children.

Swedish researchers found that patients with specific genetic mutations who took 160mg aspirin daily after colorectal cancer surgery were 55% less likely to experience cancer recurrence over three years.

Linear Diagnostics has received £1 million in NIHR funding to develop a rapid diagnostic test that can detect sexually transmitted infections in as little as five minutes using their Exponential Amplification technology.

Newcastle University scientists led by Dr. Shoba Amarnath have discovered why over 60% of cancer patients fail to respond to immune checkpoint blockade therapy, identifying regulatory T cells as key drivers of resistance.

FibroFind, a Newcastle University spin-out specializing in fibrotic disease drug development, has been acquired by private equity firm Vespa Capital to accelerate international growth.

Newcastle University scientists have developed ReJI, a 3D bioprinting technology that creates human-like tissue with 10 times higher cell density than existing methods, potentially improving drug testing accuracy.

University of Birmingham researchers are revolutionizing cancer diagnosis through innovative MRI and machine learning techniques that can identify pediatric brain tumor types in just ten minutes.